Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Trade Secrets: TCS to take $70 million hit after US Supreme Court rejects appeal

by AIP Online Bureau | Jun 16, 2026 | Indian News, Risk Management, Technology | 0 comments

The case ​stems from a 2019 lawsuit filed in Dallas federal ​court by DXC’s predecessor, Computer Sciences Corporation, which accused TCS of ‌hiring ⁠around 2,200 Transamerica, another insurance company, employees and using their inside access to build a rival life-insurance platform.

Mumbai:Tata Consultancy Services (TCS.NS) will book a one-time exceptional charge of $70 million after the U.S. Supreme Court rejected its ​appeal in a trade secrets case, bringing its total ‌exposure in the matter to $220 million, the firm said on Monday.

Here are some more details:

The U.S. Supreme Court on June 15 ​let stand a $168 million damages award in favour of ​DXC Technology. TCS, which had already set aside $150 million ⁠for the case, said it will book a further $70 ​million towards damages, interest and legal costs as a one-time ​exceptional charge in the first quarter of 2027.

The Indian firm’s net profit in the fourth quarter stood at Rs137.18 billion ($1.45 billion).\

The case ​stems from a 2019 lawsuit filed in Dallas federal ​court by DXC’s predecessor, Computer Sciences Corporation, which accused TCS of ‌hiring ⁠around 2,200 Transamerica, another insurance company, employees and using their inside access to build a rival life-insurance platform.

A jury in 2023 recommended TCS pay $210 million for willfully stealing trade ​secrets, but U.S. ​District Judge ⁠Brantley Starr cut that to $168 million, $56 million in compensatory and $112 million in punitive damages, a ​decision the 5th U.S. Circuit Court of ​Appeals upheld ⁠in 2025.

TCS argued to the Supreme Court that DXC should not have won unjust enrichment damages without proving actual ⁠losses, and ​that the punitive award was ​excessive. DXC said the lower court’s ruling needed no further review.

Reuters

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • (no title)
  • Hitesh Joshi appointed as CMD of GIC Re
  • India limits cough syrup sales to pharmacies after contamination cases
  • Institutional investors rush for GIC Re shares; issue subscribed nearly 4X on day 1
  • Trade Secrets: TCS to take $70 million hit after US Supreme Court rejects appeal

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy